Efficacy of somatostatine analogues in survival and quality of life of a frail patient with poorly differentiated biliary neuroendocrine tumour

Efficacy of somatostatine analogues in survival and quality of life of a frail patient with poorly differentiated biliary neuroendocrine tumour

Authors

  • Marco Alì Dipartimento di Oncologia Medica. Humanitas Centro Catanese di Oncologia, Catania
  • Antonino D’Agostino Dipartimento di Radioterapia. Humanitas Centro Catanese di Oncologia, Catania
  • Alfio Todaro Dipartimento di Radioterapia. Humanitas Centro Catanese di Oncologia, Catania
  • Andrea Girlando Dipartimento di Radioterapia. Humanitas Centro Catanese di Oncologia, Catania
  • Marcello Ferrara Dipartimento di Chirurgia. Humanitas Centro Catanese di Oncologia, Catania
  • Rosanna Aiello Dipartimento di Oncologia Medica. Humanitas Centro Catanese di Oncologia, Catania

DOI:

https://doi.org/10.7175/cmi.v4i1S.1065

Keywords:

Neuroendocrine tumours, Chromogranin A, Octreotide LAR, Frailty

Abstract

We describe the case of a 71-year-old woman with poorly differentiated neuroendocrine tumor of third distal biliary duct and osteolytic metastasis. The patient was evaluated as a third stage of Balducci’s criteria for the recognition of frailty. The patient received radiotherapy and octreotide LAR. This treatment allowed a good tumour progression rate (18 months), a good quality of life and a good survival (35 months). The case report describes the role of octreotide in the therapy of neuroendocrine tumours, and underlines the importance of a multidisciplinary management of cancer in frail patients.

Downloads

Published

2015-10-13

Issue

Vol. 4 No. 1S (2010)

Section

Case report

License

Authors who publish with this journal agree to the following terms:
    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial 4.0 Licence that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
    4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)